The Newro Foundation's research team, Prof David Walker and Beth Morrison, have been working in collaboration with the School of Medicine, QIMR and the Department of Pathology, Hong Kong, to research the impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy.
We are excited to announce, the Australian and New Zealand Society for Immunology Inc. have recently published the findings in the following research paper. Click here to read their exciting outcomes.